This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2013)
- Cologne, DE (2015)
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Hans Christian Reinhardt
Introduction
Hans Christian Reinhardt is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of cellular biology, particularly in the context of treating disorders related to p53-deficient cells. With a total of 2 patents, Reinhardt's work has the potential to impact therapeutic strategies for various proliferative disorders.
Latest Patents
Reinhardt's latest patents focus on MAPKAP kinase-2 as a specific target for blocking the proliferation of P53-defective cells. The first patent describes compounds and pharmaceutical compositions aimed at treating cellular proliferative disorders in patients with one or more p53-deficient cells. It also includes screening assays for identifying such compounds and methods for treating these disorders. The second patent reiterates similar themes, emphasizing the importance of MAPKAP kinase-2 in developing effective treatments for these conditions.
Career Highlights
Reinhardt is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research and innovations. His work is characterized by a strong focus on the molecular mechanisms underlying cellular proliferation and the development of targeted therapies.
Collaborations
Throughout his career, Reinhardt has collaborated with esteemed colleagues, including Michael B. Yaffe and Isaac A. Manke. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Hans Christian Reinhardt's contributions to the field of cellular biology and his innovative patents highlight his role as a significant inventor. His work on MAPKAP kinase-2 offers promising avenues for treating cellular proliferative disorders, showcasing the impact of his research on future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile